Compositions targeting au-rich elements of FGF21 gene and GDF15 gene and methods of use thereof
TW202633663APending Publication Date: 2026-08-16POSEIDA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114143091
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-06
- Filing Date
- 2025-11-05
- Publication Date
- 2026-08-16
Smart Images
Figure 00000000_0000_ABST
Abstract
This disclosure generally relates to methods and compositions for functional genetic modifications at selected genomic sites, such as the FGF21 gene or the GDF15 gene. This disclosure further provides compositions and methods for genomic editing of AU-rich elements in the FGF21 and / or GDF15 genes for treating obesity-related diseases and disorders.
Need to check novelty before this filing date? Find Prior Art